| 摘要 |
THE PRESENT INVENTION RELATES TO COMPOUNDS OF FORMULA I WHERE R1A, R1B, X, R2A, R2B, W, R3, R4, AND R5 ARE AS DEFINED HEREIN AS WELL AS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF. THE COMPOUNDS HAVE BEEN SHOWN TO ACT AS MEK INHIBITORS WHICH MAY BE USEFUL IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES, LIKE CANCER AND INFLAMMATION. |
